FEBS

NCCN Debuts Roadmap for Improving Thyroid Cancer Care in Low- and Middle-Income Countries on World Stage

Retrieved on: 
Wednesday, June 14, 2023
FEBS, World Congress of Universal Documentation, Thyroid, Framework, FACE, American Academy of Otolaryngology–Head and Neck Surgery, Survival, Cancer, Research, Journal of the National Comprehensive Cancer Network, Dana–Farber Cancer Institute, Harvard Medical School, NCCN, Investment, Regius Professor of Medicine and Therapeutics, Translation, Pain management, Palliative care, FACS, Dana, Thyroid cancer, Breast cancer, Risk management, Medical device, Core, MD

PLYMOUTH MEETING, Pa. and LONDON, June 14, 2023 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) is introducing a new global resource to improve thyroid cancer care in low- and middle-income countries at the upcoming World Congress on Thyroid Cancer, in London. During the event, NCCN Senior Vice President and Chief Medical Officer, Wui-Jin Koh, MD, will present on NCCN's ongoing global work to define and advance high-quality, high-value, patient-centered cancer care. As part of that work, the non-profit alliance of leading cancer centers recently published the new NCCN Framework for Resource Stratification of NCCN Guidelines (NCCN Framework™) for Thyroid Carcinoma, available free-of-charge at NCCN.org/global. The new resource will debut in front of more than 1,000 cancer care providers from across the globe on June 17, 2023.

Key Points: 
  • NCCN Framework for Resource Stratification of the NCCN Guidelines (NCCN Framework™) for Thyroid Carcinoma to be presented at upcoming World Congress on Thyroid Cancer in London, UK.
  • PLYMOUTH MEETING, Pa. and LONDON, June 14, 2023 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) is introducing a new global resource to improve thyroid cancer care in low- and middle-income countries at the upcoming World Congress on Thyroid Cancer, in London.
  • NCCN Framework™ exists for numerous cancer types—covering more than 80 percent of cancer diagnoses—plus supportive care topics such as pain management, palliative care, and breast cancer prevention and detection.
  • The NCCN Framework™ for Thyroid Carcinoma is the first new cancer type to be added to this library in recent years.

NCCN Debuts Roadmap for Improving Thyroid Cancer Care in Low- and Middle-Income Countries on World Stage

Retrieved on: 
Wednesday, June 14, 2023
FEBS, World Congress of Universal Documentation, Thyroid, Framework, FACE, American Academy of Otolaryngology–Head and Neck Surgery, Survival, Cancer, Research, Journal of the National Comprehensive Cancer Network, Dana–Farber Cancer Institute, Harvard Medical School, NCCN, Investment, Regius Professor of Medicine and Therapeutics, Translation, Pain management, Palliative care, FACS, Dana, Thyroid cancer, Breast cancer, Risk management, Medical device, Core, MD

PLYMOUTH MEETING, Pa. and LONDON, June 14, 2023 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) is introducing a new global resource to improve thyroid cancer care in low- and middle-income countries at the upcoming World Congress on Thyroid Cancer, in London. During the event, NCCN Senior Vice President and Chief Medical Officer, Wui-Jin Koh, MD, will present on NCCN's ongoing global work to define and advance high-quality, high-value, patient-centered cancer care. As part of that work, the non-profit alliance of leading cancer centers recently published the new NCCN Framework for Resource Stratification of NCCN Guidelines (NCCN Framework™) for Thyroid Carcinoma, available free-of-charge at NCCN.org/global. The new resource will debut in front of more than 1,000 cancer care providers from across the globe on June 17, 2023.

Key Points: 
  • NCCN Framework for Resource Stratification of the NCCN Guidelines (NCCN Framework™) for Thyroid Carcinoma to be presented at upcoming World Congress on Thyroid Cancer in London, UK.
  • PLYMOUTH MEETING, Pa. and LONDON, June 14, 2023 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) is introducing a new global resource to improve thyroid cancer care in low- and middle-income countries at the upcoming World Congress on Thyroid Cancer, in London.
  • NCCN Framework™ exists for numerous cancer types—covering more than 80 percent of cancer diagnoses—plus supportive care topics such as pain management, palliative care, and breast cancer prevention and detection.
  • The NCCN Framework™ for Thyroid Carcinoma is the first new cancer type to be added to this library in recent years.

Beroni Group Published an Article Related to Single-Domain Antibodies in the FEBS Journal

Retrieved on: 
Thursday, October 28, 2021
Infection, OTCQX, Research, National Stock Exchange, Diagnosis, Neutralizing antibody, Cancer, Industry, Failure, The FEBS Journal, Perception, Capsid, Tax, Terminology, BTG, RNA, Severe acute respiratory syndrome coronavirus 2, Consultant, Nature, Forward-looking statement, Marketing, Company, CEO, OTC, National Stock Exchange of Australia, GLOBE, Sale, NSX, FEBS, Coronavirus, Pharmaceutical industry

The FEBS Journal is an international peer-reviewed non-profit society journal devoted to publishing high-quality papers reporting significant advances in the molecular life sciences.

Key Points: 
  • The FEBS Journal is an international peer-reviewed non-profit society journal devoted to publishing high-quality papers reporting significant advances in the molecular life sciences.
  • The published article is related to the scientific findings derived from Beronis current research of the development of a medical solution using single-domain antibodies (sdAbs) for the SARS-CoV-2 coronavirus.
  • Nucleocapsid protein is a major structural protein of SARS-CoV-2 and plays an important role in viral RNA packing, replication, assembly, and infection.
  • We are delighted to progress further in our coronavirus research program and to publish our new findings in the FEBS journal.

Pittcon Announces Keynote Lecture

Retrieved on: 
Tuesday, September 21, 2021
Science, FEBS, ACS, IMSF, EMBO, Wallace H. Coulter, NWO, Mass spectrometry, Congress Center, Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy, The arts, Mass, Thomson Medal, Georgia World Congress Center, Sir Hans Krebs Medal, Utrecht University, Wallace, Field, Proteomics, European Union, Faculty, Royal Netherlands Academy of Arts and Sciences, Research, Lecture, University of Georgia (Tbilisi), Education, GLOBE, Pharmaceutical industry

Pittsburgh, Pennsylvania, USA, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Pittcon is honored to announce Professor Albert J. R. Heck as the 2022 Wallace H. Coulter Lecturer.

Key Points: 
  • Pittsburgh, Pennsylvania, USA, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Pittcon is honored to announce Professor Albert J. R. Heck as the 2022 Wallace H. Coulter Lecturer.
  • The 2022 Coulter Lecture is entitled New Horizons in Mass Spectrometry: Sizing and Counting Particles by Native Mass Spectrometry.
  • Albert J. R. Heck is Distinguished Faculty Professor at the Science Faculty of Utrecht University (the Netherlands).
  • Pittcon is a catalyst for the exchange of information, a showcase of the latest advances in laboratory science, and a venue for international connectivity.